Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

NCT04130919 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor terminated the study since a new molecular entity was able to achieve greater target coverage

Conditions

Interventions

Sponsor

Gilead Sciences